77 related articles for article (PubMed ID: 36620898)
1. The Importance of Recency of Cancer Diagnosis in Patients Hospitalized with COVID-19-Glimpses from an EHR-based Study.
Egan PC; Jani C; Singh H; Mishra S; Warner JL
Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):3-5. PubMed ID: 36620898
[TBL] [Abstract][Full Text] [Related]
2. Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin.
Nolan MB; Piasecki TM; Smith SS; Baker TB; Fiore MC; Adsit RT; Bolt DM; Conner KL; Bernstein SL; Eng OD; Lazuk D; Gonzalez A; Hayes-Birchler T; Jorenby DE; D'Angelo H; Kirsch JA; Williams BS; Kent S; Kim H; Lubanski SA; Yu M; Suk Y; Cai Y; Kashyap N; Mathew J; McMahan G; Rolland B; Tindle HA; Warren GW; Abu-El-Rub N; An LC; Boyd AD; Brunzell DH; Carrillo VA; Chen LS; Davis JM; Deshmukh VG; Dilip D; Goldstein AO; Ha PK; Iturrate E; Jose T; Khanna N; King A; Klass E; Lui M; Mermelstein RJ; Poon C; Tong E; Wilson KM; Theobald WE; Slutske WS
Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):12-21. PubMed ID: 35965473
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database.
Dong X; Zhou Y; Shu XO; Bernstam EV; Stern R; Aronoff DM; Xu H; Lipworth L
Microbiol Spectr; 2021 Sep; 9(1):e0032721. PubMed ID: 34406805
[TBL] [Abstract][Full Text] [Related]
4. Predictive model for severe COVID-19 using SARS-CoV-2 whole-genome sequencing and electronic health record data, March 2020-May 2021.
Zhu L; Marsh JW; Griffith MP; Collins K; Srinivasa V; Waggle K; Van Tyne D; Snyder GM; Phan T; Wells A; Marroquin OC; Harrison LH
PLoS One; 2022; 17(7):e0271381. PubMed ID: 35819967
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Diagnosis and Risk of Death Among Adults With Cancer in Indiana: Retrospective Cohort Study.
Valvi N; Patel H; Bakoyannis G; Haggstrom DA; Mohanty S; Dixon BE
JMIR Cancer; 2022 Oct; 8(4):e35310. PubMed ID: 36201388
[TBL] [Abstract][Full Text] [Related]
6. Trends in Pediatric Viral Symptoms, Influenza Testing, and SARS-CoV-2 Testing From a Statewide Electronic Health Record Consortium, January 2017 to July 2021.
Khazanchi R; Spaulding AB; Bodurtha PJ; Neely C; Winkelman TNA;
Acad Pediatr; 2021; 21(8):1420-1425. PubMed ID: 34411765
[TBL] [Abstract][Full Text] [Related]
7. Data gaps in electronic health record (EHR) systems: An audit of problem list completeness during the COVID-19 pandemic.
Poulos J; Zhu L; Shah AD
Int J Med Inform; 2021 Jun; 150():104452. PubMed ID: 33864979
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
9. Electronic Health Record-Based Surveillance for Community Transmitted COVID-19 in the Emergency Department.
Pulia MS; Hekman DJ; Glazer JM; Barclay-Buchanan C; Kuehnel N; Ross J; Sharp B; Batt R; Patterson BW
West J Emerg Med; 2020 May; 21(4):748-751. PubMed ID: 32726234
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 outcomes in patients with cancer: Findings from the University of California health system database.
Kwon DH; Cadena J; Nguyen S; Chan KHR; Soper B; Gryshuk AL; Hong JC; Ray P; Huang FW
Cancer Med; 2022 Jun; 11(11):2204-2215. PubMed ID: 35261195
[TBL] [Abstract][Full Text] [Related]
11. Association of Shared Living Spaces and COVID-19 in University Students, Wisconsin, USA, 2020.
Bigouette JP; Ford L; Segaloff HE; Langolf K; Kahrs J; Zochert T; Tate JE; Gieryn D; Kirking HL; Westergaard RP; Killerby ME
Emerg Infect Dis; 2021 Nov; 27(11):2882-2886. PubMed ID: 34670651
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
13. Severity of COVID-19 and adverse long-term outcomes: a retrospective cohort study based on a US electronic health record database.
Jovanoski N; Chen X; Becker U; Zalocusky K; Chawla D; Tsai L; Borm M; Neighbors M; Yau V
BMJ Open; 2021 Dec; 11(12):e056284. PubMed ID: 34893488
[TBL] [Abstract][Full Text] [Related]
14. Risk of New Hospitalization Post-COVID-19 Infection for Non-COVID-19 Conditions.
Mainous AG; Rooks BJ; Orlando FA
J Am Board Fam Med; 2021; 34(5):907-913. PubMed ID: 34535516
[TBL] [Abstract][Full Text] [Related]
15. Risk of COVID-19 diagnosis and death in patients with mental illness: a cohort study.
Seon JY; Kim S; Hong M; Lim MK; Oh IH
Epidemiol Psychiatr Sci; 2021 Oct; 30():e68. PubMed ID: 34645538
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of Computable Phenotyping Approaches for SARS-CoV-2 Infection and COVID-19 Hospitalizations from the Electronic Health Record.
Khera R; Mortazavi BJ; Sangha V; Warner F; Young HP; Ross JS; Shah ND; Theel ES; Jenkinson WG; Knepper C; Wang K; Peaper D; Martinello RA; Brandt CA; Lin Z; Ko AI; Krumholz HM; Pollock BD; Schulz WL
medRxiv; 2021 May; ():. PubMed ID: 34013299
[TBL] [Abstract][Full Text] [Related]
17. International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study.
Weber GM; Zhang HG; L'Yi S; Bonzel CL; Hong C; Avillach P; Gutiérrez-Sacristán A; Palmer NP; Tan ALM; Wang X; Yuan W; Gehlenborg N; Alloni A; Amendola DF; Bellasi A; Bellazzi R; Beraghi M; Bucalo M; Chiovato L; Cho K; Dagliati A; Estiri H; Follett RW; García Barrio N; Hanauer DA; Henderson DW; Ho YL; Holmes JH; Hutch MR; Kavuluru R; Kirchoff K; Klann JG; Krishnamurthy AK; Le TT; Liu M; Loh NHW; Lozano-Zahonero S; Luo Y; Maidlow S; Makoudjou A; Malovini A; Martins MR; Moal B; Morris M; Mowery DL; Murphy SN; Neuraz A; Ngiam KY; Okoshi MP; Omenn GS; Patel LP; Pedrera Jiménez M; Prudente RA; Samayamuthu MJ; Sanz Vidorreta FJ; Schriver ER; Schubert P; Serrano Balazote P; Tan BW; Tanni SE; Tibollo V; Visweswaran S; Wagholikar KB; Xia Z; Zöller D; ; Kohane IS; Cai T; South AM; Brat GA
J Med Internet Res; 2021 Oct; 23(10):e31400. PubMed ID: 34533459
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
[TBL] [Abstract][Full Text] [Related]
19. Characterization of test positivity among patients with coronavirus disease 2019 (COVID-19) in three electronic health records databases, February-November 2020.
Saunders-Hastings P; Zhou CK; Hobbi S; Wong HL; Lloyd P; Boyd E; Alawar N; Clarke TC; Beers J; Burrell T; Shoaibi A
BMC Public Health; 2022 Jun; 22(1):1217. PubMed ID: 35717174
[TBL] [Abstract][Full Text] [Related]
20. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
